Common use of Efficacy Clause in Contracts

Efficacy. When tested against Pseudomonas aeruginosa in 30 minutes achieves at least a 4.0 log reduction at time zero and a log reduction of 3.0 throughout the shelf life. Reference WI-8.2.4-2.033. • Maintains antimicrobial activity when tested as demonstrated by a 3 day plate to plate CZOI efficacy test against Pseudomonas aeruginosa and Staphylococcus aureus, where a CZOI of at least 3 mm is maintained. Reference WI-8.2.4-2.034.

Efficacy. When tested against Pseudomonas aeruginosa and Staphylococcus aureus in 30 minutes 4 hours achieves at least a 4.0 log reduction at time zero and a log reduction of 3.0 throughout the shelf life. Reference WI-8.2.4-2.033. • Maintains antimicrobial activity when tested as demonstrated by a 3 day plate to plate CZOI efficacy test against Pseudomonas aeruginosa and Staphylococcus aureus, where a CZOI of at least 3 mm is maintained. Reference WI-8.2.4-2.034WI-8.

Efficacy. When tested against Pseudomonas aeruginosa and Staphylococcus aureus in 30 minutes 2 hours achieves at least a 4.0 log reduction at time zero and a log reduction of 3.0 throughout the shelf life. Reference WI-8.2.4-2.0332.017. • Maintains antimicrobial activity when tested as demonstrated by a 3 day plate to plate CZOI efficacy test against Pseudomonas aeruginosa and Staphylococcus aureus, where a CZOI of at least 3 mm is maintained. Reference WI-8.2.4-2.034.

Efficacy. When tested against Pseudomonas aeruginosa and Staphylococcus aureus in 30 minutes 2 hours achieves at least a 4.0 log reduction at time zero and a log reduction of 3.0 throughout the shelf life. Reference WI-8.2.4-2.033. • Maintains antimicrobial activity when tested as demonstrated by a 3 day plate to plate CZOI efficacy test against Pseudomonas aeruginosa and Staphylococcus aureus, where a CZOI of at least 3 mm is maintained. Reference WI-8.2.4-2.034WI-8.